Wykazuje take waciwoci przeciwzapalne i, wedug niektrych bada, potencjalnie neuroprotekcyjne, co przekada si na szersze moliwoci zastosowa terapeutycznych
However, a post hoc analysis of semaglutide trials found no increased risk of kidney-related adverse events compared with active comparators [113]
It improves blood sugar control, reduces weight, and may lower the risk of cardiovascular events like heart attacks and strokes
Recalls & Warnings April 08, 2026 FDA Warns Consumers Not to Use Addall Shots or Supplements On April 3, 2026, the FDA warned consumers not to use Addall XR Shot and Addall XL capsules, products promoted for energy and focus, after FDA testing found they contain undeclared drug ingredients that are not permitted in dietary supplements and may pose serious health risks
10.1186/s13578-022-00914-3 91 SpeliotesE
When is retatrutide expected to be FDA-approved